IRVINE, CA, December 02, 2008
/24-7PressRelease/ -- ProstimRx pioneered the development of a patented medical device and process for the treatment of prostate-related disorders. This process and equipment has been successfully used in over 10,000 clinical cases for the treatment of prostatitis, benign prostate hypertrophy ("BPH"), erectile dysfunction and other diseases associated with the prostate, including lower urinary tract symptoms ("LUTS"), infertility, and male sexual dysfunction.
The Company holds an exclusive and perpetual license to the U.S. patent on the medical device. The potential for the ProstimRx treatment process and medical device is vast as prostate disease and dysfunction is one of the most widespread medically related problems seen in the healthcare industry today. ProstimRx will augment or replace the current treatment of
antimicrobial therapy, which most often does not adequately treat the underlying problems and which have associated side effects. In addition, ProstimRx has been successfully used in the treatment of male sexual dysfunction associated with prostate related problems.
Jeff Brinkman, Chief Executive Officer of ProstimRx, commented that, "We are very pleased to have M.D. Venture Partners support ProstimRx in the global commercialization of our patented process for treating prostatitis and related prostate disorders. We intend to use the investment capital to obtain a 510(k) clearance from the U.S. Food and Drug Administration and CEmark from the European Union, obtain empirical data on the medical device treatment and longterm outcomes through clinical trials, initiate marketing of the medical device to the healthcare industry, and improve prostate patient outcomes around the world."
For additional information, please contact Lauren Michelle at M.D. Venture Partners.
For additional information on ProstimRx Corporation, e-mail info@prostimrx.com.
About M.D. Venture Partners
M.D. Venture Partners (www.mdventurepartners.com) Provides Venture Capital, Management and Medical Expertise from The Largest Network of Physician Investors in America To BuildWorld Class Healthcare Technology Companies and Deliver Exceptional Results.
# # #
Other Press Release Headlines:- "Making Green in a Downward Real Estate Market" Might Just Boost Your Confidence. The article, by Sonya Rose, is Featured in Georgia Realty Magazine Online at http://www.georgiarealtymagazine.com
- Columbus, Ohio: Sudden Cardiac Death, Left Ventricle Hypertrophy and Dilation, Cardiac Disease, Cardiac Failure and Cardiac Disease Associated with Obstructive Sleep Apnea. Dental Sleep Medicine, Oral Appliances and CPAP Reduce the Risk. WWW.IHATECPAP.com Saves Lives by Offering CPAP Alternatives.
- International Circus Festival of Tomorrow in Paris
- Call for Papers: Cloud Slam '09, First Virtual Conference on Cloud Computing, April 20-24, 2009
- Scio Consulting Partners with Apprenda for Rapid SaaS Product Enablement
- CPAP Alternatives: Columbus, Ohio Dentist Provides Valuable Sleep Apnea Information. Dr Mark Levy promotes the Availability of Multiple Treatment Choices for the Treatment of Obstructive Sleep Apnea. Vitally Important Information is Available at www.IHATECPAP.COM
- Sleep Apnea Treatment: Sleep Apnea Information and the Availability of Treatment Choices for the Treatment of Obstructive Sleep Apnea Including CPAP, Surgery and Oral Appliances is Available at www.IHATECPAP.COM - Patients Prefer Oral Appliances To CPAP
- New Website Developed By Board Certified Plastic Surgeon Ideal For Anyone Interested In Learning About The Latest Cosmetic Surgical And Non-Surgical Procedures
- Sustainable Energy Appoints Chief Operating Officer (TSX VENTURE:STG)
- Saving Money In a Slowing Economy Where Every Dollar Saved Counts
